American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis

被引：1078

作者：

Hahn, Bevra H. ^{[1
]}

McMahon, Maureen A.

Wilkinson, Alan

Wallace, W. Dean

Daikh, David I. ^{[2
]}

Fitzgerald, John D.

Karpouzas, George A.

Merrill, Joan T. ^{[3
]}

Wallace, Daniel J. ^{[4
]}

Yazdany, Jinoos ^{[2
]}

Ramsey-Goldman, Rosalind ^{[5
]}

Singh, Karandeep

Khalighi, Mazdak

Choi, Soo-In

Gogia, Maneesh

Kafaja, Suzanne

Kamgar, Mohammad

Lau, Christine

Martin, William J.

Parikh, Sefali

Peng, Justin

Rastogi, Anjay

Chen, Weiling

Grossman, Jennifer M.

机构：

[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA

[4] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[5] Northwestern Univ, Chicago, IL 60611 USA

来源：

ARTHRITIS CARE & RESEARCH | 2012年 / 64卷 / 06期

关键词：

STAGE RENAL-DISEASE; RANDOMIZED CONTROLLED-TRIAL; MYCOPHENOLATE-MOFETIL; LONG-TERM; CYCLOPHOSPHAMIDE THERAPY; PULSE CYCLOPHOSPHAMIDE; INTRAVENOUS CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE THERAPY; MAINTENANCE THERAPY; COMBINATION THERAPY;

D O I：

10.1002/acr.21664

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient. The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances. Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome. Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice. The American College of Rheumatology is an independent, professional, medical and scientific society which does not guarantee, warrant, or endorse any commercial product or service.

引用

页码：797 / 808

页数：12

共 79 条

[1] Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].

Agodoa, LY ;

Appel, L ;

Bakris, GL ;

Beck, G ;

Bourgoignie, J ;

Briggs, JP ;

Charleston, J ;

Cheek, D ;

Cleveland, W ;

Douglas, JG ;

Douglas, M ;

Dowie, D ;

Faulkner, M ;

Gabriel, A ;

Gassman, J ;

Greene, T ;

Hall, Y ;

Hebert, L ;

Hiremath, L ;

Jamerson, K ;

Johnson, CJ ;

Kopple, J ;

Kusek, J ;

Lash, J ;

Lea, J ;

Lewis, JB ;

Lipkowitz, M ;

Massry, S ;

Middleton, J ;

Miller, ER ;

Norris, K ;

O'Connor, D ;

Ojo, A ;

Phillips, RA ;

Pogue, V ;

Rahman, M ;

Randall, OS ;

Rostand, S ;

Schulman, G ;

Smith, W ;

Thornley-Brown, D ;

Tisher, CC ;

Toto, RD ;

Wright, JT ;

Xu, SC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728

[2] Baseline characteristics of a multiethnic lupus cohort:: PROFILE [J].

Alarcón, GS ;

McGwin, G ;

Petri, M ;

Reveille, JD ;

Ramsey-Goldman, R ;

Kimberly, RP .

LUPUS, 2002, 11 (02) :95-101

[3]

[Anonymous], J AM SOC NEPHROLOGY

[4]

[Anonymous], 2011, Micromedex 2.0

[5] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis [J].

Appel, Gerald B. ;

Contreras, Gabriel ;

Dooley, Mary Anne ;

Ginzler, Ellen M. ;

Isenberg, David ;

Jayne, David ;

Li, Lei-Shi ;

Mysler, Eduardo ;

Sanchez-Guerrero, Jorge ;

Solomons, Neil ;

Wofsy, David .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05) :1103-1112

[6] THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].

AUSTIN, HA ;

KLIPPEL, JH ;

BALOW, JE ;

LERICHE, NGH ;

STEINBERG, AD ;

PLOTZ, PH ;

DECKER, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619

[7] Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy [J].

Austin, Howard A., III ;

Illei, Gabor G. ;

Braun, Michelle J. ;

Balow, James E. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (04) :901-911

[8] Successful treatment of class V+IV lupus nephritis with multitarget therapy [J].

Bao, Hao ;

Liu, Zhi-Hong ;

Xie, Hong-Lang ;

Hu, Wei-Xin ;

Zhang, Hai-Tao ;

Li, Lei-Shi .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (10) :2001-2010

[9] Mortality in systemic lupus erythematosus [J].

Bernatsky, S. ;

Boivin, J. -F. ;

Joseph, L. ;

Manzi, S. ;

Ginzler, E. ;

Gladman, D. D. ;

Urowitz, M. ;

Fortin, P. R. ;

Petri, M. ;

Barr, S. ;

Gordon, C. ;

Bae, S. -C. ;

Isenberg, D. ;

Zoma, A. ;

Aranow, C. ;

Dooley, M. -A. ;

Nived, O. ;

Sturfelt, G. ;

Steinsson, K. ;

Alarcon, G. ;

Senecal, J. -L. ;

Zummer, M. ;

Hanly, J. ;

Ensworth, S. ;

Pope, J. ;

Edworthy, S. ;

Rahman, A. ;

Sibley, J. ;

El-Gabalawy, H. ;

McCarthy, T. ;

Pierre, Y. St. ;

Clarke, A. ;

Ramsey-Goldman, R. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2550-2557

[10] RISK FOR SUSTAINED AMENORRHEA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING INTERMITTENT PULSE CYCLOPHOSPHAMIDE THERAPY [J].

BOUMPAS, DT ;

AUSTIN, HA ;

VAUGHAN, EM ;

YARBORO, CH ;

KLIPPEL, JH ;

BALOW, JE .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :366-369

← 1 2 3 4 5 6 7 8 →